These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 871431)

  • 21. An exon 10 deletion in the mouse ferrochelatase gene has a dominant-negative effect and causes mild protoporphyria.
    Magness ST; Maeda N; Brenner DA
    Blood; 2002 Aug; 100(4):1470-7. PubMed ID: 12149233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzymatic defects in porphyria: an overview.
    Elder GH
    Semin Liver Dis; 1982 May; 2(2):87-99. PubMed ID: 6753167
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunochemical studies of ferrochelatase protein: characterization of the normal and mutant protein in bovine and human protoporphyria.
    Straka JG; Hill HD; Krikava JM; Kools AM; Bloomer JR
    Am J Hum Genet; 1991 Jan; 48(1):72-8. PubMed ID: 1985464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug sensitivity in hereditary hepatic porphyria.
    Meyer UA
    Hum Genet Suppl; 1978; (1):71-8. PubMed ID: 285036
    [No Abstract]   [Full Text] [Related]  

  • 25. Zinc chelatase in human lymphocytes: detection of the enzymatic defect in erythropoietic protoporphyria.
    Nunn AV; Norris P; Hawk JL; Cox TM
    Anal Biochem; 1988 Oct; 174(1):146-50. PubMed ID: 3218729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease.
    Tutois S; Montagutelli X; Da Silva V; Jouault H; Rouyer-Fessard P; Leroy-Viard K; Guénet JL; Nordmann Y; Beuzard Y; Deybach JC
    J Clin Invest; 1991 Nov; 88(5):1730-6. PubMed ID: 1939658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzyme defects in the porphyrias and their relevance to the biochemical abnormalities in these disorders.
    Bloomer JR
    J Invest Dermatol; 1981 Jul; 77(1):102-6. PubMed ID: 7252240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haem biosynthesis in cutaneous hepatic porphyria: comparison with alcoholism and liver disease.
    Brodie MJ; Thompson GG; Moore MR; McColl KE; Goldberg A; Hardie RA; Hunter JA
    Acta Hepatogastroenterol (Stuttg); 1979 Apr; 26(2):122-8. PubMed ID: 463487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heme synthetase activity in normal human and rat erythroid cells and in sideroblastic anemia.
    Verhoef NJ; Noordeloos PJ; Leijnse B
    Clin Chim Acta; 1978 Jan; 82(1-2):45-53. PubMed ID: 618683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inheritance in protoporphyria. Comparison of haem synthetase activity in skin fibroblasts with clinical features.
    Bloomer JR; Bonkowsky HL; Ebert PS; Mahoney MJ
    Lancet; 1976 Jul; 2(7979):226-8. PubMed ID: 59242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ferrochelatase consisting of wild-type and mutated subunits from patients with a dominant-inherited disease, erythropoietic protoporphyria, is an active but unstable dimer.
    Ohgari Y; Sawamoto M; Yamamoto M; Kohno H; Taketani S
    Hum Mol Genet; 2005 Jan; 14(2):327-34. PubMed ID: 15574461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular defect of ferrochelatase in a patient with erythropoietic protoporphyria.
    Nakahashi Y; Fujita H; Taketani S; Ishida N; Kappas A; Sassa S
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):281-5. PubMed ID: 1729699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ferrochelatase activity in human lymphocytes: effect of storage on haem formation.
    Tovey JA; Elder GH
    Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():80-1. PubMed ID: 2310162
    [No Abstract]   [Full Text] [Related]  

  • 34. The ferrochelatase gene structure and molecular defects associated with erythropoietic protoporphyria.
    Taketani S; Fujita H
    J Bioenerg Biomembr; 1995 Apr; 27(2):231-8. PubMed ID: 7592570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of porphyrias in Italy: a diagnostic flow-chart.
    Martinez di Montemuros F; Di Pierro E; Patti E; Tavazzi D; Danielli MG; Biolcati G; Rocchi E; Cappellini MD
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):867-76. PubMed ID: 12699245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human erythropoietic protoporphyria: two point mutations in the ferrochelatase gene.
    Lamoril J; Boulechfar S; de Verneuil H; Grandchamp B; Nordmann Y; Deybach JC
    Biochem Biophys Res Commun; 1991 Dec; 181(2):594-9. PubMed ID: 1755842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic heterogeneity in erythropoietic protoporphyria: a study of the enzymatic defect in nine affected families.
    Norris PG; Nunn AV; Hawk JL; Cox TM
    J Invest Dermatol; 1990 Sep; 95(3):260-3. PubMed ID: 2384686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haplotype analysis of families with erythropoietic protoporphyria and novel mutations of the ferrochelatase gene.
    Wang X; Yang L; Kurtz L; Lichtin A; DeLeo VA; Bloomer J; Poh-Fitzpatrick MB
    J Invest Dermatol; 1999 Jul; 113(1):87-92. PubMed ID: 10417624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late-onset erythropoietic porphyria caused by a chromosome 18q deletion in erythroid cells.
    Aplin C; Whatley SD; Thompson P; Hoy T; Fisher P; Singer C; Lovell CR; Elder GH
    J Invest Dermatol; 2001 Dec; 117(6):1647-9. PubMed ID: 11886534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation.
    Bloomer J; Bruzzone C; Zhu L; Scarlett Y; Magness S; Brenner D
    J Clin Invest; 1998 Jul; 102(1):107-14. PubMed ID: 9649563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.